Monte Rosa Therapeutics, Inc. (GLUE)
10.30
-0.02
(-0.19%)
USD |
NASDAQ |
Oct 09, 16:00
10.30
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Price to Book Value : 1.802 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.802 |
| October 08, 2026 | 1.805 |
| October 07, 2026 | 1.779 |
| October 06, 2026 | 1.726 |
| October 05, 2026 | 1.796 |
| October 02, 2026 | 1.836 |
| October 01, 2026 | 1.969 |
| September 30, 2026 | 2.087 |
| September 29, 2026 | 2.053 |
| September 28, 2026 | 2.048 |
| September 25, 2026 | 2.059 |
| September 24, 2026 | 2.050 |
| September 23, 2026 | 2.080 |
| September 22, 2026 | 2.204 |
| September 21, 2026 | 2.144 |
| September 18, 2026 | 2.122 |
| September 17, 2026 | 2.204 |
| September 16, 2026 | 2.212 |
| September 15, 2026 | 2.272 |
| September 14, 2026 | 2.431 |
| September 11, 2026 | 2.461 |
| September 10, 2026 | 2.505 |
| September 09, 2026 | 2.494 |
| September 08, 2026 | 2.496 |
| September 04, 2026 | 2.421 |
| Date | Value |
|---|---|
| September 03, 2026 | 2.515 |
| September 02, 2026 | 2.487 |
| September 01, 2026 | 2.503 |
| August 31, 2026 | 2.438 |
| August 28, 2026 | 2.340 |
| August 27, 2026 | 2.505 |
| August 26, 2026 | 2.515 |
| August 25, 2026 | 2.547 |
| August 24, 2026 | 2.409 |
| August 21, 2026 | 2.501 |
| August 20, 2026 | 2.585 |
| August 19, 2026 | 2.758 |
| August 18, 2026 | 2.629 |
| August 17, 2026 | 2.69 |
| August 14, 2026 | 2.711 |
| August 13, 2026 | 2.770 |
| August 12, 2026 | 2.790 |
| August 11, 2026 | 2.756 |
| August 10, 2026 | 2.767 |
| August 07, 2026 | 2.777 |
| August 06, 2026 | 2.748 |
| August 05, 2026 | 2.730 |
| August 04, 2026 | 2.812 |
| August 03, 2026 | 2.69 |
| July 31, 2026 | 2.889 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| United Therapeutics Corp. | 3.662 |
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.98 |
| Anika Therapeutics, Inc. | 1.909 |
| Savara, Inc. | 7.034 |
Price to Book Value Related Metrics
| PS Ratio | 31.31 |
| Price | 10.30 |
| Earnings Yield | -18.50% |
| Market Cap | 877.83M |